The goal of this clinical trial is to asses the effect of Coenzyme Q10 administration in patients from any gender group who are older than 18 years old undergoing wisdom tooth extraction. The main questions it aims to answer are: does Coenzyme Q10 help with better tissue healing? does Coenzyme Q10 administration lower the prevalence of Dry socket after surgery? does Coenzyme Q10 prevent TMD (Temporomandibular disorders) while recovering from surgery? how does Coenzyme Q10 administration effect the answers to SF-36 health survey in patients? Researchers will compare Coenzyme Q10 to a placebo (a look-alike substance that contains no drug) to see if it has any effect on mentioned parameters. Participants will: * take coenzyme Q10 (100mg) daily for 30 days after surgery. * will be examined and evaluated 1, 7, 14 and 30 days after completion of surgery.
Inclusion Criteria: * Patients older than 18 years old that require mandibular or maxillary molar, third tooth extraction as Oral and Maxillofacial surgeon's clinical diagnosis. Exclusion Criteria: * The patient's departure from Sanandaj * The patient's disagreement with the study protocol * The Patient's demise * The patient's hospitalization for unrelated illnesses * The patient's discontent with the care they received * The patient's failure to show up for follow-up appointments * The patient's sensitivity to Coenzyme Q10